相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol
Kai-Dietrich Nuesken et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
Su-Ryun Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study
Ravi Retnakaran et al.
CLINICAL ENDOCRINOLOGY (2008)
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Raghu Adya et al.
CARDIOVASCULAR RESEARCH (2008)
Molecular characteristics of serum visfatin and differential detection by immunoassays
Antje Koerner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Kenji Oki et al.
CLINICAL ENDOCRINOLOGY (2007)
Serum levels of adipokine retinol-binding protein-4 in relation to renal function
Michaela Ziegelmeier et al.
DIABETES CARE (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes
Susan Kralisch et al.
REGULATORY PEPTIDES (2006)
Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle
H Sell et al.
ENDOCRINOLOGY (2006)
Inflammation and the etiology of type 2 diabetes
A Sjoholm et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Inflammation, stress, and diabetes
KE Wellen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT
JM Bruun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes
M Fasshauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes
M Fasshauer et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Chemokines in the pathogenesis of vascular disease
IF Charo et al.
CIRCULATION RESEARCH (2004)
Monocyte chemoattractant protein 1 in obesity and insulin resistance
P Sartipy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes
M Fasshauer et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The perils of portliness - Causes and consequences of visceral adiposity
CT Montagne et al.
DIABETES (2000)
分享论文
